Hackshaw, Allan https://orcid.org/0000-0002-5570-5070
Cohen, Sarah S.
Reichert, Heidi
Kansal, Anuraag R.
Chung, Karen C.
Ofman, Joshua J.
Funding for this research was provided by:
Cancer Research UK (C444/A15953)
Grail Inc
Article History
Received: 24 February 2021
Revised: 30 June 2021
Accepted: 12 July 2021
First Online: 23 August 2021
Competing interests
: AH is co-investigator for an academic study (SUMMIT) sponsored by UCL, which is funded by GRAIL, and has received one honorarium for an advisory board meeting for GRAIL and a consulting fee from Evidera Inc (for a GRAIL-initiated project); and previously owned shares in Illumina. He received no payment for participating in the project in this paper. ARK, KCC and JJO are employees of GRAIL. The remaining authors declare no competing interests.
: This study only used publicly available summary data therefore ethics approval and patient consent are not applicable.